These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9593558

  • 21. Heart rate-lowering calcium antagonists in hypertensive post-myocardial infarction patients.
    Messerli FH, Hansen JF, Gibson RS, Schechtman KB, Boden WE.
    J Hypertens; 2001 May; 19(5):977-82. PubMed ID: 11393682
    [Abstract] [Full Text] [Related]

  • 22. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
    Tsai MS, Tang CH, Lin CY, Chuang PY, Chen NC, Huang CH, Chang WT, Wang TD, Yu PH, Chen WJ.
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
    [Abstract] [Full Text] [Related]

  • 23. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
    Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW.
    N Engl J Med; 1998 Mar 05; 338(10):645-52. PubMed ID: 9486993
    [Abstract] [Full Text] [Related]

  • 24. Prevalence of use of beta blockers and of calcium channel blockers in older patients with prior myocardial infarction at the time of admission to a nursing home.
    Aronow WS.
    J Am Geriatr Soc; 1996 Sep 05; 44(9):1075-7. PubMed ID: 8790234
    [Abstract] [Full Text] [Related]

  • 25. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S, Bakir SE.
    Drugs; 2000 Sep 05; 59 Spec No 2():25-37. PubMed ID: 11002856
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Influences of Smoking Status on Effectiveness of Cytochrome P450 Enzyme System Metabolized Medications in Reducing In-Hospital Death in 14 658 Patients With Acute Myocardial Infarction: Data From CPACS-3 Study.
    Li M, Feng L, Li X, Gao R, Wu Y.
    J Cardiovasc Pharmacol Ther; 2020 Sep 05; 25(5):418-424. PubMed ID: 32338045
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ, CONVINCE Research Group.
    JAMA; 2020 Sep 05; 289(16):2073-82. PubMed ID: 12709465
    [Abstract] [Full Text] [Related]

  • 30. The calcium channel blocker controversy in perspective.
    Zanchetti A.
    Cardiology; 1997 Sep 05; 88 Suppl 1():66-70; discussion 71-2. PubMed ID: 9118170
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients.
    Ogawa H, Kim-Mitsuyama S, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K, OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study Group.
    Am J Med; 2012 Oct 05; 125(10):981-90. PubMed ID: 22503610
    [Abstract] [Full Text] [Related]

  • 33. Managing the hypertensive patient with ischemic heart disease.
    Rosendorff C.
    Curr Hypertens Rep; 2002 Oct 05; 4(5):350-7. PubMed ID: 12217252
    [Abstract] [Full Text] [Related]

  • 34. Pharmacological interventions for hypertension in children.
    Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.
    Evid Based Child Health; 2014 Sep 05; 9(3):498-580. PubMed ID: 25236305
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use.
    Bourgault C, Elstein E, Baltzan MA, Le Lorier J, Suissa S.
    Pharmacoepidemiol Drug Saf; 2001 Sep 05; 10(4):287-94. PubMed ID: 11760488
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.